Estrogen suppression in males: Metabolic effects

Journal of Clinical Endocrinology and Metabolism

Volumn 85, Issue 7, 2000, Pages 2370-2377

  Mauras, Nelly ^a   O'Brien, Kimberly O ^c   Klein, Karen Oerter ^b   Hayes, Valerie ^a  

^a NEMOURS CHILDREN S CLINIC   (United States)

^b NEMOURS ALFRED I DUPONT HOSPITAL FOR CHILDREN   (United States)

^c JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALKALINE PHOSPHATASE; ANASTROZOLE; ANDROGEN; ANTIESTROGEN; OSTEOCALCIN; SEX HORMONE BINDING GLOBULIN; SOMATOMEDIN; TESTOSTERONE;

ABSORPTIOMETRY; ADOLESCENT; ADULT; ARTICLE; BODY COMPOSITION; BONE TURNOVER; CALCIFICATION; CALCIUM BONE LEVEL; CALCIUM METABOLISM; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; ENZYME INHIBITION; GROWTH RETARDATION; HORMONE INHIBITION; HUMAN; HUMAN EXPERIMENT; MALE; NORMAL HUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN SYNTHESIS;

ADOLESCENT; ADULT; ANTINEOPLASTIC AGENTS, HORMONAL; BODY COMPOSITION; BONE AND BONES; CALCIUM; ESTRADIOL; ESTROGEN ANTAGONISTS; GROWTH SUBSTANCES; HORMONES; HUMAN GROWTH HORMONE; HUMANS; KETO ACIDS; KINETICS; LEUPROLIDE; MALE; MUSCLE, SKELETAL; NITRILES; PROTEINS; TRIAZOLES;

EID: 0034456785     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jc.85.7.2370     Document Type: Article

References (49)

1. Testosterone deficiency in young men: Marked alterations in whole body protein kinetics, strength and adiposity
2. Calcium and protein kinetics in prepubertal boys. Positive effects of testosterone
3. Short-term oxandrolone administration stimulates net muscle protein synthesis in young men
4. Estrogens do not affect whole-body protein metabolism in the prepubertal female
5. Estrogen and testosterone, but not a nonaromatizable androgen, direct network integration of the hypothalamo-somatotrope (growth hormone)- insulin-like growth factor I axis in the human: Evidence from pubertal pathophysiology and sex-steroid hormone replacement
6. Estrogen receptor blockade with tamoxifen diminishes GH secretion in boys: Evidence of a stimulatory role of endogenous estrogens during male adolescence
7. Estrogen resistance caused by a mutation in the estrogen-receptor gene in a man
8. Aromatase deficiency in male and female siblings caused by a novel mutation and the physiological role of estrogens
9. Effect of Testosterone and estradiol in man with aromatase deficiency
10. The effects of the estrogen receptor blocker, Faslodex (ICI 182,780), on estrogen-accelerated bone maturation in mice
11. Arimidex: A potent and selective fourth-generation aromatase inhibitor
12. Arimidex: A potent, and selective fourth generation aromatase inhibitor
13. ARIMIDEX: A new oral, once-a-day aromatase inhibitor
14. A randomised trial comparing two doses of the new selective aromatase inhibitor anastrozole (Arimidex) with megestrol acetate in postmenopausal patients with advanced breast cancer
15. Estrogen levels in childhood determined by an ultrasensitive recombinant cell bioassay
16. Heated dorsal hand vein sampling for metabolic studies: A reappraisal
17. Use of t-butyldimethyl silyation in gas chromatographic mass spectrometric analysis of physiologic compounds found in plasma using electron impact ionization
18. Use of reciprocal pool specific activities to model leucine metabolism in humans
19. 20
20. Recent studies of human calcium metabolism using stable isotope tracers
21. Low basal and persistent pulsatile growth hormone secretion are revealed in normal and hyposomatotropic men studied with a new ultrasensitive chemiluminescence assay
22. Dual tracer stable isotopic assessment of calcium absorption and endogenous fecal excretion in low birth weight infants
23. Developmental changes in calcium kinetics in children assessed using stable isotopes
24. Multicompartmental analysis of calcium kinetics in normal adult males
25. The theoretical bases of indirect calorimetry: A review
26. Body fat assessed from total body density and its estimation from skinfold thickness: Measurements on 481 men and women aged from 16 to 72 years
27. Profound hypogonadism has significant negative effects on calcium balance in males: A calcium kinetic study
28. Estradiol and testosterone secretion by human, simian, and canine testes, in males with hypogonadism and in male pseudohermaphrodites with the feminizing testes syndrome
29. Estrogen formation in the brain
30. Conversion of androstenedione to estrone by human tissue
31. Secretion and metabolism of adrenal androgens to estrogens
32. Aromatization of androgens by muscle and adipose tissue in vivo
33. Aromatization of androstenedione by isolated human hairs
34. Aromatase in human bone tissue
35. The functions of cortisol binding globulin and sex hormone binding globulin: Recent advances
36. Sex hormone-binding globulin mediates steroid hormone signal transduction at the plasma membrane
37. Sex steroid control of gonadotropin secretion in the human male. II. Effects of estradiol administration in normal and gonadotropin- releasing hormone-deficient men
38. The direct pituitary effect of testosterone to inhibit gonadotropin secretion in men is partially mediated by aromatization to estradiol
39. Differential effects of estrogen and GH on uterine and hepatic insulin-like growth factor-I expression in the ovariectomized hypophysectomized rat
40. Effects of recombinant human growth hormone on metabolic indices, body composition, and bone turnover in healthy elderly women
41. Skeletal effects of estrogen
42. Androgens as anabolic agents for bone
43. Combined treatment with gonadotropin-releasing hormone analog and growth hormone in central precocious puberty
44. Final height after combined growth hormone and gonadotrophin-releasing hormone analogue therapy in short healthy children entering into normally timed puberty
45. GH and GnRH analog treatment in children who enter puberty at short stature
46. Is obesity an outcome of gonadotropin-releasing hormone agonist administration? Analysis of growth and body composition in 110 patients with central precocious puberty
47. Long-term outcome after depot gonadotropin-releasing hormone agonist treatment of central precocious puberty: Final height, body proportions, body composition, bone mineral density, and reproductive function
48. Bone mineral density and body composition before and during treatment with gonadotropin-releasing hormone agonist in children with precocious and early puberty